The American Heart Association awarded its Population Research Prize to JoAnn Manson, M.D., Dr.P.H., of Boston, for "exceptional achievement" as the leader of clinical trials clarifying major aspects of preventive medicine and women's health.
Manson, chief of the Division of Preventive Medicine at Brigham and Women's Hospital and Harvard Medical School in Boston, received the $5,000 prize during the opening of the American Heart Association Scientific Sessions 2010 in Chicago's McCormick Place Convention Center.
Association President Ralph Sacco, M.D., presented the award, which annually recognizes merit in cardiovascular science by the head of a major population research laboratory.
"Dr. Manson has been making historic progress expanding knowledge of heart disease and stroke risk, especially in women," Sacco said. "Her contributions are of great relevance to understanding and overcoming critical biological and generic determinants of disease. She has emphasized the role of lifestyle factors including physical activity, diet, nutrient supplementation and post-menopausal hormone therapy as predictors of cardiovascular outcomes in women."
Landmark studies led by Manson that have impacted medical care and public health include the cardiovascular component of the Nurses' Health Study; the Women's Antioxidant and Folic Acid Cardiovascular Study; the Boston site of the Women's Health Initiative, and VITAL, the first large-scale trial of vitamin D and omega 3s in the primary prevention of cardiovascular diseases and cancer.
"Indeed, JoAnn Manson has taken the study of population health and translational research to the highest level," Sacco said in presenting the AHA prize.
Manson's previous honors include election as a Fellow of the American Association for the Advancement of Science. She has been a member of Harvard's medical faculty since 1987.
Source:
American Heart Association
Комментариев нет:
Отправить комментарий